Moleculin Biotech
MBRX
MBRX
26 hedge funds and large institutions have $2.04M invested in Moleculin Biotech in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$45.7K | |
| 2 | +$44.3K | |
| 3 | +$21K | |
| 4 |
Squarepoint
New York
|
+$10K |
| 5 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$10K |
Top Sellers
| 1 | -$181K | |
| 2 | -$27.1K | |
| 3 | -$20.4K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$5.06K |
| 5 |
Barclays
London,
United Kingdom
|
-$4.66K |